Role of Salivary MicroRNA and Cytokines in the Diagnosis and Prognosis of Oral Squamous Cell Carcinoma

Int J Mol Sci. 2021 Nov 11;22(22):12215. doi: 10.3390/ijms222212215.

Abstract

Oral squamous cell carcinoma (OSCC) is the most prevalent oral malignant tumor worldwide. An early diagnosis can have a major positive impact on its prognosis. Human saliva contains cytokines, DNA and RNA molecules, circulating cells, and derivatives of tissues and extracellular vesicles, among other factors that can serve as biomarkers. Hence, the analysis of saliva may provide useful information for the early diagnosis of OSCC for its prognosis. The objective of this review was to determine the potential usefulness of salivary biomarkers (cytokines and microRNA) to diagnose OSCC and improve its prognosis. A combination of salivary miRNA and proteomic data could allow a definitive and early diagnosis to be obtained. However, there remains a need to optimize and standardize the protocols used to quantify miRNAs.

Keywords: cytokines; diagnosis; microRNA; oral cancer; oral pathology; salivary biomarker.

Publication types

  • Review

MeSH terms

  • Biomarkers, Tumor / metabolism*
  • Cytokines / metabolism*
  • Humans
  • MicroRNAs / metabolism*
  • Mouth Neoplasms* / diagnosis
  • Mouth Neoplasms* / metabolism
  • Neoplasm Proteins / metabolism*
  • Prognosis
  • RNA, Neoplasm / metabolism*
  • Saliva / metabolism*
  • Salivary Proteins and Peptides / metabolism*
  • Squamous Cell Carcinoma of Head and Neck* / diagnosis
  • Squamous Cell Carcinoma of Head and Neck* / metabolism

Substances

  • Biomarkers, Tumor
  • Cytokines
  • MicroRNAs
  • Neoplasm Proteins
  • RNA, Neoplasm
  • Salivary Proteins and Peptides